Receptor Activator of NF-κB and Osteoprotegerin Expression by Human Microvascular Endothelial Cells, Regulation by Inflammatory Cytokines, and Role in Human Osteoclastogenesis

Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation.

Lacey, D. L., Timms, E., Tan, H.-L., Kelley, M. J., Dunstan, C. R., Burgess, T., Elliott, R., Colombero, A., Elliott, G., Scully, S., et al. (1998) · Cell · doi:10.1016/s0092-8674(00)81569-x · Cited by 5,439 · see citing works

Osteoprotegerin: a novel secreted protein involved in the regulation of bone density.

Simonet, W. S., Lacey, D. L., Dunstan, C. R., Kelley, M., Chang, M.-S., Lüthy, R., Nguyen, H. Q., Wooden, S., Bennett, L., Boone, T., et al. (1997) · Cell · doi:10.1016/s0092-8674(00)80209-3 · Cited by 5,130 · see citing works

Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL

Yasuda, H., Shima, N., Nakagawa, N., Yamaguchi, K., Kinosaki, M., Mochizuki, S.-I., Tomoyasu, A., Yano, K., Goto, M., Murakami, A., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.7.3597 · Cited by 4,224 · see citing works

OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph node organogenesis.

Kong, Y.-Y., Yoshida, H., Sarosi, I., Tan, H.-L., Timms, E., Capparelli, C., Morony, S., Oliveira-dos-Santos, A. J., Van, G., Itie, A., et al. (1999) · Nature · doi:10.1038/16852 · Cited by 3,351 · see citing works

Osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification.

Bucay, N., Sarosi, I., Dunstan, C. R., Morony, S., Tarpley, J., Capparelli, C., Scully, S., Tan, H. L., Xu, W., Lacey, D. L., et al. (1998) · Genes & Development · doi:10.1101/gad.12.9.1260 · Cited by 2,483 · see citing works

Modulation of Osteoclast Differentiation and Function by the New Members of the Tumor Necrosis Factor Receptor and Ligand Families

Suda, T., Takahashi, N., Udagawa, N., Jimi, E., Gillespie, M. T., & Martin, T. J. (1999) · Endocrine Reviews · doi:10.1210/edrv.20.3.0367 · Cited by 2,317 · see citing works

Endothelial cells in physiology and in the pathophysiology of vascular disorders.

Cines, D. B., Pollak, E. S., Buck, C. A., Loscalzo, J., Zimmerman, G. A., McEver, R. P., Pober, J. S., Wick, T. M., Konkle, B. A., Schwartz, B. S., et al. (1998) · PubMed · doi:10.1182/blood.v91.10.3527 · Cited by 2,244 · see citing works

VEGF couples hypertrophic cartilage remodeling, ossification and angiogenesis during endochondral bone formation

Gerber, H. P., Vu, T. H., Ryan, A. M., Kowalski, J., Werb, Z., & Ferrara, N. (1999) · Nature Medicine · doi:10.1038/9467 · Cited by 2,089 · see citing works

Tumor necrosis factor receptor family member RANK mediates osteoclast differentiation and activation induced by osteoprotegerin ligand.

Hsu, H., Lacey, D. L., Dunstan, C. R., Solovyev, I., Colombero, A., Timms, E., Tan, H.-L., Elliott, G., Kelley, M. J., Sarosi, I., et al. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.7.3540 · Cited by 1,636 · see citing works

Identity of Osteoclastogenesis Inhibitory Factor (OCIF) and Osteoprotegerin (OPG): A Mechanism by which OPG/OCIF Inhibits Osteoclastogenesis<i>in Vitro</i>¹

Yasuda, H., Shima, N., Nakagawa, N., Mochizuki, S.-I., Yano, K., Fujise, N., Sato, Y., Goto, M., Yamaguchi, K., Kuriyama, M., et al. (1998) · Endocrinology · doi:10.1210/endo.139.3.5837 · Cited by 1,201 · see citing works

The Roles of Osteoprotegerin and Osteoprotegerin Ligand in the Paracrine Regulation of Bone Resorption

Hofbauer, L. C., Khosla, S., Dunstan, C. R., Lacey, D. L., Boyle, W. J., & Riggs, B. L. (2000) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2000.15.1.2 · Cited by 1,167 · see citing works

Severe osteoporosis in mice lacking osteoclastogenesis inhibitory factor/osteoprotegerin.

Mizuno, A., Amizuka, N., Irie, K., Murakami, A., Fujise, N., Kanno, T., Sato, Y., Nakagawa, N., Yasuda, H., Mochizuki, S.-I., et al. (1998) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1998.8697 · Cited by 775 · see citing works

RANK Is the Essential Signaling Receptor for Osteoclast Differentiation Factor in Osteoclastogenesis

Nakagawa, N., Kinosaki, M., Yamaguchi, K., Shima, N., Yasuda, H., Yano, K., Morinaga, T., & Higashio, K. (1998) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1998.9788 · Cited by 746 · see citing works

The codependence of angiogenesis and chronic inflammation

Jackson, J. R., Seed, M. P., Kircher, C. H., Willoughby, D. A., & Winkler, J. D. (1997) · The FASEB Journal · doi:10.1096/fasebj.11.6.9194526 · Cited by 690 · see citing works

Cytokine regulation of endothelial cell function

Mantovani, A., Bussolino, F., & Dejana, E. (1992) · The FASEB Journal · doi:10.1096/fasebj.6.8.1592209 · Cited by 677 · see citing works

Differentiation of human bone marrow osteogenic stromal cells in vitro: induction of the osteoblast phenotype by dexamethasone

Cheng, S., Yang, J., Rifas, L., Zhang, S. F., & Avioli, L. V. (1994) · Endocrinology · doi:10.1210/endo.134.1.8275945 · Cited by 647 · see citing works

Interleukin-1β and tumor necrosis factor-α, but not interleukin-6, stimulate osteoprotegerin ligand gene expression in human osteoblastic cells

Hofbauer, L. C., Lacey, D. L., Dunstan, C. R., Spelsberg, T. C., Riggs, B. L., & Khosla, S. (1999) · Bone · doi:10.1016/s8756-3282(99)00162-3 · Cited by 630 · see citing works

TRANCE Is Necessary and Sufficient for Osteoblast-mediated Activation of Bone Resorption in Osteoclasts

Fuller, K., Wong, B., Fox, S. W., Choi, Y., & Chambers, T. J. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.5.997 · Cited by 562 · see citing works

Osteoprotegerin reverses osteoporosis by inhibiting endosteal osteoclasts and prevents vascular calcification by blocking a process resembling osteoclastogenesis.

Min, H., Morony, S., Sarosi, I., Dunstan, C. R., Capparelli, C., Scully, S., Van, G., Kaufman, S., Kostenuik, P. J., Lacey, D. L., et al. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.4.463 · Cited by 550 · see citing works

Breast Cancer Cells Interact with Osteoblasts to Support Osteoclast Formation1

Thomas, R. J., Guise, T. A., Yin, J. J., Elliott, J., Horwood, N. J., Martin, T. J., & Gillespie, M. T. (1999) · Endocrinology · doi:10.1210/endo.140.10.7037 · Cited by 536 · see citing works

Parathyroid hormone stimulates TRANCE and inhibits osteoprotegerin messenger ribonucleic acid expression in murine bone marrow cultures: correlation with osteoclast-like cell formation.

Lee, S.-K., & Lorenzo, J. A. (1999) · Endocrinology · doi:10.1210/endo.140.8.6887 · Cited by 464 · see citing works

Osteotropic Agents Regulate the Expression of Osteoclast Differentiation Factor and Osteoprotegerin in Osteoblastic Stromal Cells

Horwood, N. J., Elliott, J., Martin, T. J., & Gillespie, M. T. (1998) · Endocrinology · doi:10.1210/endo.139.11.6433 · Cited by 456 · see citing works

THE ROLE OF THE VESSELS IN OSTEOGENESIS

Trueta, J. (1963) · Journal of Bone and Joint Surgery - British Volume · doi:10.1302/0301-620x.45b2.402 · Cited by 454 · see citing works

Changes in trabecular bone, hematopoiesis and bone marrow vessels in aplastic anemia, primary osteoporosis, and old age: A comparative histomorphometric study

Burkhardt, R., Kettner, G., Böhm, W., Schmidmeier, M., Schlag, R., Frisch, B., Mallmann, B., Eisenmenger, W., & Gilg, T. (1987) · Bone · doi:10.1016/8756-3282(87)90015-9 · Cited by 452 · see citing works

Immunological characterization of circulating osteoprotegerin/osteoclastogenesis inhibitory factor: increased serum concentrations in postmenopausal women with osteoporosis.

Yano, K., Tsuda, E., Washida, N., Kobayashi, F., Goto, M., Harada, A., Ikeda, K., Higashio, K., & Yamada, Y. (1999) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.1999.14.4.518 · Cited by 363 · see citing works

Osteoprotegerin Is an αvβ3-induced, NF-κB-dependent Survival Factor for Endothelial Cells

Malyankar, U. M., Scatena, M., Suchland, K. L., Yun, T. J., Clark, E. A., & Giachelli, C. M. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.c000290200 · Cited by 348 · see citing works

Osteoclast Differentiation Factor (ODF) Induces Osteoclast-like Cell Formation in Human Peripheral Blood Mononuclear Cell Cultures

Matsuzaki, K., Udagawa, N., Takahashi, N., Yamaguchi, K., Yasuda, H., Shima, N., Morinaga, T., Toyama, Y., Yabe, Y., Higashio, K., et al. (1998) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1998.8586 · Cited by 337 · see citing works

Localization of RANKL (receptor activator of NFκB ligand) mRNA and protein in skeletal and extraskeletal tissues

Kartsogiannis, V., Zhou, H., Horwood, N. J., Thomas, R. J., Hards, D. K., Quinn, J. M. W., Niforas, P., Ng, K. W., Martin, T. J., & Gillespie, M. T. (1999) · Bone · doi:10.1016/s8756-3282(99)00214-8 · Cited by 324 · see citing works

Osteoprotegerin Production by Human Osteoblast Lineage Cells Is Stimulated by Vitamin D, Bone Morphogenetic Protein-2, and Cytokines

Hofbauer, L. C., Dunstan, C. R., Spelsberg, T. C., Riggs, B. L., & Khosla, S. (1998) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1998.9394 · Cited by 311 · see citing works

Potentiation of osteoclast bone-resorption activity by inhibition of nitric oxide synthase.

Kasten, T. P., Collin‐Osdoby, P., Patel, N., Osdoby, P., Krukowski, M., Misko, T. P., Settle, S. L., Currie, M. G., & Nickols, G. A. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.9.3569 · Cited by 242 · see citing works

Osteoclast Differentiation Factor Mediates an Essential Signal for Bone Resorption Induced by 1α,25-Dihydroxyvitamin D3, Prostaglandin E2, or Parathyroid Hormone in the Microenvironment of Bone

Tsukii, K., Shima, N., Mochizuki, S.-I., Yamaguchi, K., Kinosaki, M., Yano, K., Shibata, O., Udagawa, N., Yasuda, H., Suda, T., et al. (1998) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1998.8610 · Cited by 237 · see citing works

TRANCE is a TNF family member that regulates dendritic cell and osteoclast function

Wong, B. R., Josien, R., & Choi, Y. (1999) · Journal of Leukocyte Biology · doi:10.1002/jlb.65.6.715 · Cited by 230 · see citing works

Prostaglandin E2 Cooperates with TRANCE in Osteoclast Induction from Hemopoietic Precursors: Synergistic Activation of Differentiation, Cell Spreading, and Fusion

Wani, M. R., Fuller, K., Kim, N. S., Choi, Y., & Chambers, T. J. (1999) · Endocrinology · doi:10.1210/endo.140.4.6647 · Cited by 172 · see citing works

Role of vascular endothelial cells in bone biology

Collin‐Osdoby, P. (1994) · Journal of Cellular Biochemistry · doi:10.1002/jcb.240550306 · Cited by 171 · see citing works

Starving the synovium: angiogenesis and inflammation in rheumatoid arthritis

Firestein, G. S. (1999) · Journal of Clinical Investigation · doi:10.1172/jci5929 · Cited by 162 · see citing works

Estrogen’s bone-protective effects may involve differential IL-1 receptor regulation in human osteoclast-like cells

Sunyer, T., Lewis, J., Collin‐Osdoby, P., & Osdoby, P. (1999) · Journal of Clinical Investigation · doi:10.1172/jci4682 · Cited by 139 · see citing works

Potential Role of Cbfa1, an Essential Transcriptional Factor for Osteoblast Differentiation, in Osteoclastogenesis: Regulation of mRNA Expression ofOsteoclast Differentiation Factor(ODF)

Gao, Y., Shinki, T., Yuasa, T., Kataoka-Enomoto, H., Komori, T., Suda, T., & Yamaguchi, A. (1998) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1998.9643 · Cited by 131 · see citing works

Osteoprotegerin and osteoprotegerin ligand effects on osteoclast formation from human peripheral blood mononuclear cell precursors

Shalhoub, V., Faust, J., Boyle, W. J., Dunstan, C. R., Kelley, M., Kaufman, S., Scully, S. A., Van, G. Y., & Lacey, D. L. (1999) · Journal of Cellular Biochemistry · doi:10.1002/(sici)1097-4644(19990201)72:2 · Cited by 123 · see citing works

Reciprocal gene expression of osteoclastogenesis inhibitory factor and osteoclast differentiation factor regulates osteoclast formation.

Nagai, M., & Sato, N. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.0524 · Cited by 111 · see citing works

Osteoprotegerin mRNA Is Increased by Interleukin-1α in the Human Osteosarcoma Cell Line MG-63 and in Human Osteoblast-Like Cells

Vidal, O., Sjögren, K., Eriksson, B. I., Ljunggren, Ö., & Ohlsson, C. (1998) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1998.9035 · Cited by 105 · see citing works

Osteoclast markers accumulate on cells developing from human peripheral blood mononuclear precursors

Faust, J., Lacey, D., Hunt, P., Burgess, T. L., Scully, S. A., Van, G. Y., Eli, A., Qian, Y., & Shalhoub, V. (1999) · Journal of Cellular Biochemistry · doi:10.1002/(sici)1097-4644(19990101)72:1 · Cited by 105 · see citing works

Human Osteoclasts and Osteoclast-Like Cells Synthesize and Release High Basal and Inflammatory Stimulated Levels of the Potent Chemokine Interleukin-81

Rothe, L., Collin‐Osdoby, P., Chen, Y., Sunyer, T., Chaudhary, L. R., Tsay, A., Goldring, S. R., Avioli, L. V., & Osdoby, P. (1998) · Endocrinology · doi:10.1210/endo.139.10.6247 · Cited by 103 · see citing works

Tumor Necrosis Factor-α and -β Upregulate the Levels of Osteoprotegerin mRNA in Human Osteosarcoma MG-63 Cells

Brändström, H., Jonsson, K. B., Vidal, O., Ljunghall, S., Ohlsson, C., & Ljunggren, Ö. (1998) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1998.8993 · Cited by 102 · see citing works

Human Mesenchymal Stem Cells Promote Human Osteoclast Differentiation from CD34+ Bone Marrow Hematopoietic Progenitors

Mbalaviele, G., Jaiswal, N., Meng, A., Cheng, L., van den Bos, C., & Thiede, M. A. (1999) · Endocrinology · doi:10.1210/endo.140.8.6880 · Cited by 99 · see citing works

Biology of bone endothelial cells

Streeten, E. A., & Brandi, M. L. (1990) · Bone and Mineral · doi:10.1016/0169-6009(90)90084-s · Cited by 93 · see citing works

Osteoclast precursors as leukocytes: importance of the area code

PARFITT, A. M. (1998) · Bone · doi:10.1016/s8756-3282(98)00140-9 · Cited by 89 · see citing works

Role of the endothelial cell in osteoclast control: New perspectives

Zaidi, M., Alam, A. S. M. T., Bax, B. E., Shankar, V. S., Bax, C. M. R., Gill, J. S., Pazianas, M., Huang, C. L.-H., Sahinoglu, T., Moonga, B. S., et al. (1993) · Bone · doi:10.1016/8756-3282(93)90234-2 · Cited by 80 · see citing works

Decreased Nitric Oxide Levels Stimulate Osteoclastogenesis and Bone Resorption Both in Vitro and in Vivo on the Chick Chorioallantoic Membrane in Association with Neoangiogenesis

Collin‐Osdoby, P., Rothe, L., Bekker, S., Anderson, F. L., & Osdoby, P. (2000) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2000.15.3.474 · Cited by 73 · see citing works

Bone remodelling: A signalling system for osteoclast regulation

Filvaroff, E. H., & Derynck, R. (1998) · Current Biology · doi:10.1016/s0960-9822(98)70434-8 · Cited by 66 · see citing works

Cloned endothelial cells from fetal bovine bone.

Streeten, E. A., Ornberg, R., Curcio, F., Sakaguchi, K., Marx, S. J., Aurbach, G. D., & Brandi, M. L. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.3.916 · Cited by 46 · see citing works

Glucocorticoid modulation of prostacyclin production in cultured bovine pulmonary endothelial cells.

Crutchley, D. J., Ryan, U., & Ryan, J. W. (1985) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)22886-5 · Cited by 30 · see citing works

Induction of early growth response-1 gene by interleukin-1? and tumor necrosis factor-? in normal human bone marrow stromal and osteoblastic cells: regulation by a protein kinase C inhibitor

Chaudhary, L. R., Cheng, S., & Avioli, L. V. (1996) · Molecular and Cellular Biochemistry · doi:10.1007/bf00239321 · Cited by 28 · see citing works

Expression of human N-myristoyltransferase inEscherichia coli. Comparison with N-myristoyltransferases expressed in different tissues

Raju, R. V. S., Datla, R. S. S., & Sharma, R. K. (1996) · Molecular and Cellular Biochemistry · doi:10.1007/bf00714335 · Cited by 26 · see citing works

Osteoclast 121F antigen expression during osteoblast conditioned medium induction of osteoclast-like cells in vitro: Relationship to calcitonin responsiveness, tartrate resistant acid phosphatase levels, and bone resorptive activity

Collin‐Osdoby, P., Oursler, M. J., Rothe, L., Webber, D. M., Anderson, F. L., & Osdoby, P. (1995) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650100109 · Cited by 22 · see citing works

Microvascular invasion of rabbit growth plate cartilage and the influence of dexamethasone

Brown, R. A., Rees, J. A., McFarland, C., Lewinson, D., & ALI, S. Y. (1990) · Bone and Mineral · doi:10.1016/0169-6009(90)90098-z · Cited by 19 · see citing works

The osteoclast-endothelium interface during bone resorption in the femurs of young rabbits

Soskolne, W. A. (1979) · Cell and Tissue Research · doi:10.1007/bf00233276 · Cited by 8 · see citing works

Untitled work

(1998) · doi:10.1002/1529-0131(199806)41:6

Matrix-embedded cells control osteoclast formation

Xiong, J., Onal, M., Jilka, R. L., Weinstein, R. S., Manolagas, S. C., & O'Brien, C. A. (2011) · Nature Medicine · doi:10.1038/nm.2448 · Cited by 1,304 · see citing works

Vascular Calcification

Demer, L. L., & Tintut, Y. (2008) · Circulation · doi:10.1161/circulationaha.107.743161 · Cited by 1,071 · see citing works

Osteogenesis and angiogenesis: The potential for engineering bone

Kanczler, J. M., & Oreffo, R. (2008) · European Cells and Materials · doi:10.22203/ecm.v015a08 · Cited by 984 · see citing works

Receptor Activator of Nuclear Factor κB Ligand and Osteoprotegerin Regulation of Bone Remodeling in Health and Disease

Kearns, A. E., Khosla, S., & Kostenuik, P. J. (2008) · Endocrine Reviews · doi:10.1210/er.2007-0014 · Cited by 824 · see citing works

The molecular triad OPG/RANK/RANKL: involvement in the orchestration of pathophysiological bone remodeling

Theoleyre, S., Wittrant, Y., Tat, S. K., Fortun, Y., Redini, F., & Heymann, D. (2004) · Cytokine &amp; Growth Factor Reviews · doi:10.1016/j.cytogfr.2004.06.004 · Cited by 663 · see citing works

Mechanisms of TNF-α– and RANKL-mediated osteoclastogenesis and bone resorption in psoriatic arthritis

Ritchlin, C. T., Haas-Smith, S. A., Li, P., Hicks, D. G., & Schwarz, E. M. (2003) · Journal of Clinical Investigation · doi:10.1172/jci16069 · Cited by 613 · see citing works

An overview of the regulation of bone remodelling at the cellular level

Kular, J., Tickner, J. C., Chim, S. M., & Xu, J. (2012) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2012.03.021 · Cited by 536 · see citing works

Bone remodeling: an operational process ensuring survival and bone mechanical competence

Bolamperti, S., Villa, I., & Rubinacci, A. (2022) · Bone Research · doi:10.1038/s41413-022-00219-8 · Cited by 482 · see citing works

Regulation of Vascular Calcification by Osteoclast Regulatory Factors RANKL and Osteoprotegerin

Collin‐Osdoby, P. (2004) · Circulation Research · doi:10.1161/01.res.0000149165.99974.12 · Cited by 469 · see citing works

Modeling the interactions between osteoblast and osteoclast activities in bone remodeling

Lemaire, V., Tobin, F. L., Greller, L. D., Cho, C. R., & Suva, L. J. (2004) · Journal of Theoretical Biology · doi:10.1016/j.jtbi.2004.03.023 · Cited by 452 · see citing works

RANK Ligand and Osteoprotegerin

Schoppet, M., Preissner, K. T., & Hofbauer, L. C. (2002) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000012303.37971.da · Cited by 403 · see citing works

Vitamin D and Bone Health; Potential Mechanisms

Laird, E. J., Ward, M., McSorley, E. M., Strain, J., & Wallace, J. M. W. (2010) · Nutrients · doi:10.3390/nu2070693 · Cited by 359 · see citing works

Vascular Biology and the Skeleton

Brandi, M. L., & Collin‐Osdoby, P. (2006) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.050917 · Cited by 334 · see citing works

Arterial calcification and bone physiology: role of the bone–vascular axis

Thompson, B., & Towler, D. A. (2012) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2012.36 · Cited by 336 · see citing works

The effects of estrogen on osteoprotegerin, RANKL, and estrogen receptor expression in human osteoblasts.

Bord, S., Ireland, D. C., Beavan, S. R., & Compston, J. E. (2003) · Bone · doi:10.1016/s8756-3282(02)00953-5 · Cited by 333 · see citing works

Vascular calcification and bone disease: the calcification paradox

Persy, V. P., & D’Haese, P. C. (2009) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2009.07.001 · Cited by 333 · see citing works

A Physical Mechanism for Coupling Bone Resorption and Formation in Adult Human Bone

Andersen, T. L., Sondergaard, T. E., Skorzynska, K. E., Dagnaes-Hansen, F., Plesner, T. L., Hauge, E. M., Plesner, T., & Delaisse, J.-M. (2009) · The American Journal of Pathology · doi:10.2353/ajpath.2009.080627 · Cited by 325 · see citing works

Increased Osteoprotegerin Serum Levels in Men with Coronary Artery Disease

Schoppet, M., Sattler, A., Schaefer, J. R., Herzum, M., Maisch, B., & Hofbauer, L. C. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-020775 · Cited by 322 · see citing works

Vitamin K and vitamin D status: associations with inflammatory markers in the Framingham Offspring Study

Shea, M. K., Booth, S. L., Massaro, J. M., Jacques, P. F., D'Agostino, R. B., Dawson-Hughes, B., Ordovas, J. M., O'Donnell, C. J., Kathiresan, S., Keaney, J. F., et al. (2007) · American Journal of Epidemiology · doi:10.1093/aje/kwm306 · Cited by 316 · see citing works

Osteoprotegerin, vascular calcification and atherosclerosis

Campenhout, A. V., & Golledge, J. (2008) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2008.09.033 · Cited by 309 · see citing works

Molecular, Endocrine, and Genetic Mechanisms of Arterial Calcification

Doherty, T. M., Fitzpatrick, L. A., Inoue, D., Qiao, J.-H., Fishbein, M. C., Detrano, R., Shah, P. K., & Rajavashisth, T. B. (2004) · Endocrine Reviews · doi:10.1210/er.2003-0015 · Cited by 298 · see citing works

Angiogenic factors in bone local environment

Chim, S. M., Tickner, J. C., Chow, S. T., Kuek, V., Guo, B., Zhang, G., Rosen, V., Erber, W. N., & Xu, J. (2013) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2013.03.008 · Cited by 267 · see citing works

TNF.ALPHA. and pathologic bone resorption

Boyce, B., Li, P., Yao, Z., Zhang, Q., Badell, I. R., Schwarz, E. M., O’Keefe, R. J., & Xing, L. (2005) · The Keio Journal of Medicine · doi:10.2302/kjm.54.127 · Cited by 260 · see citing works

Osteoprotegerin Inhibits Vascular Calcification Without Affecting Atherosclerosis in <i> ldlr ^(−/−) </i> Mice

Morony, S., Tintut, Y., Zhang, Z., Cattley, R. C., Van, G., Dwyer, D., Stolina, M., Kostenuik, P. J., & Demer, L. L. (2008) · Circulation · doi:10.1161/circulationaha.107.707380 · Cited by 258 · see citing works

Stromal Cell-Derived Factor-1 (SDF-1) Recruits Osteoclast Precursors by Inducing Chemotaxis, Matrix Metalloproteinase-9 (MMP-9) Activity, and Collagen Transmigration

Yu, X., Huang, Y., Collin‐Osdoby, P., & Osdoby, P. (2003) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2003.18.8.1404 · Cited by 241 · see citing works

Matrix Metalloproteinases in Bone Resorption, Remodeling, and Repair

Paiva, K. B. S., & Granjeiro, J. M. (2017) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2017.05.001 · Cited by 237 · see citing works

Stromal cell-derived factor-1 binding to its chemokine receptor CXCR4 on precursor cells promotes the chemotactic recruitment, development and survival of human osteoclasts

Wright, L. M., Maloney, W. J., YU, X., Kindle, L., Collin‐Osdoby, P., & Osdoby, P. (2005) · Bone · doi:10.1016/j.bone.2005.01.021 · Cited by 231 · see citing works

RANK Signaling Is Not Required for TNFα-Mediated Increase in CD11bhi Osteoclast Precursors but Is Essential for Mature Osteoclast Formation in TNFα-Mediated Inflammatory Arthritis

Li, P., Schwarz, E. M., O'Keefe, R. J., Ma, L., Boyce, B. F., & Xing, L. (2004) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.0301233 · Cited by 220 · see citing works

CCR1 Chemokines Promote the Chemotactic Recruitment, RANKL Development, and Motility of Osteoclasts and Are Induced by Inflammatory Cytokines in Osteoblasts

Yu, X., Huang, Y., Collin‐Osdoby, P., & Osdoby, P. (2004) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.040910 · Cited by 219 · see citing works

Apoptotic Bodies Convey Activity Capable of Initiating Osteoclastogenesis and Localized Bone Destruction

Kogianni, G., Mann, V., & Noble, B. (2008) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.080207 · Cited by 221 · see citing works

Circulating Osteoprotegerin and Receptor Activator for Nuclear Factor κB Ligand: Clinical Utility in Metabolic Bone Disease Assessment

Rogers, A., & Eastell, R. (2005) · The Journal of Clinical Endocrinology &amp; Metabolism · doi:10.1210/jc.2005-0794 · Cited by 215 · see citing works

TNF-Related Activation-Induced Cytokine Enhances Leukocyte Adhesiveness: Induction of ICAM-1 and VCAM-1 via TNF Receptor-Associated Factor and Protein Kinase C-Dependent NF-κB Activation in Endothelial Cells

Min, J., Kim, Y., Kim, S. W., Kwon, M.-C., Kong, Y., Hwang, I. K., Won, M. H., Rho, J., & Kwon, Y. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.1.531 · Cited by 211 · see citing works

OSCAR is a collagen receptor that costimulates osteoclastogenesis in DAP12-deficient humans and mice

Barrow, A. D., Raynal, N., Andersen, T. L., Slatter, D. A., Bihan, D. G., Pugh, N., Cella, M., Kim, T. S., Rho, J., Negishi‐Koga, T., et al. (2011) · Journal of Clinical Investigation · doi:10.1172/jci45913 · Cited by 207 · see citing works

Systemic tumor necrosis factor α mediates an increase in peripheral CD11bhigh osteoclast precursors in tumor necrosis factor α–transgenic mice

Li, P., Schwarz, E., O'Keefe, R., Ma, L., Looney, R., Ritchlin, C., Boyce, B., & Xing, L. (2004) · Arthritis & Rheumatism · doi:10.1002/art.11419 · Cited by 180 · see citing works

High levels of osteoprotegerin and soluble receptor activator of nuclear factor κB ligand in serum of rheumatoid arthritis patients and their normalization after anti-tumor necrosis factor α treatment.

Ziolkowska, M., Kurowska, M., Radzikowska, A., Luszczykiewicz, G., Wiland, P., Dziewczopolski, W., Filipowicz‐Sosnowska, A., Pazdur, J., Szechinski, J., Kowalczewski, J., et al. (2002) · Arthritis &amp; Rheumatism · doi:10.1002/art.10388 · Cited by 200 · see citing works

Osteoclasts are important for bone angiogenesis

Cackowski, F. C., Anderson, J. L., Patrene, K. D., Choksi, R. J., Shapiro, S. D., Windle, J. J., Blair, H. C., & Roodman, G. D. (2010) · Blood · doi:10.1182/blood-2009-08-237628 · Cited by 188 · see citing works

Localization of Osteoprotegerin, Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand, and Receptor Activator of Nuclear Factor-κB Ligand in Monckeberg’s Sclerosis and Atherosclerosis

Schoppet, M., Al‐Fakhri, N., Franke, F. E., Katz, N. R., Barth, P. J., Maisch, B., Preissner, K. T., & Hofbauer, L. C. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-031432 · Cited by 184 · see citing works

In vitro Models of Bone Remodelling and Associated Disorders

Owen, R., & Reilly, G. C. (2018) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2018.00134 · Cited by 181 · see citing works

Pathogenesis of calciphylaxis: Hans Selye to nuclear factor κ-B

Weenig, R. H. (2008) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2007.12.006 · Cited by 181 · see citing works

Cancer and the Microenvironment

Yaccoby, S., Wezeman, M. J., Henderson, A., Cottler‐Fox, M., Yi, Q., Barlogie, B., & Epstein, J. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-1131 · Cited by 181 · see citing works

Runx2-Upregulated Receptor Activator of Nuclear Factor κB Ligand in Calcifying Smooth Muscle Cells Promotes Migration and Osteoclastic Differentiation of Macrophages

Byon, C. H., Sun, Y., Chen, J., Yuan, K., Mao, X., Heath, J. M., Anderson, P. G., Tintut, Y., Demer, L. L., Wang, D., et al. (2011) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.110.222547 · Cited by 172 · see citing works

Atherosclerosis and osteoporosis: age-dependent degenerative processes or related entities?

Anagnostis, P. G., Karagiannis, A. I., Kakafika, A. I., Τζιόμαλος, Κ., Athyros, V. G., & Mikhailidis, D. P. (2008) · Osteoporosis International · doi:10.1007/s00198-008-0648-5 · Cited by 171 · see citing works

RANKL, RANK, osteoprotegerin: key partners of osteoimmunology and vascular diseases

Baud’huin, M., Lamoureux, F., Duplomb, L., Rédiní, F., & Heymann, D. (2007) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-007-7104-0 · Cited by 171 · see citing works

The insulin-like growth factor-I gene and osteoporosis: A critical appraisal

Niu, T., & Rosen, C. J. (2005) · Gene · doi:10.1016/j.gene.2005.07.016 · Cited by 171 · see citing works

Osteoprotegerin (OPG) is localized to the Weibel‐Palade bodies of human vascular endothelial cells and is physically associated with von Willebrand factor

Zannettino, A. C. W., Holding, C. A., Diamond, P., Atkins, G. J., Kostakis, P., Farrugia, A., Gamble, J. R., To, L. B., Findlay, D. M., & Haynes, D. R. (2005) · Journal of Cellular Physiology · doi:10.1002/jcp.20354 · Cited by 166 · see citing works

NF-κB p50 and p52 Expression Is Not Required for RANK-Expressing Osteoclast Progenitor Formation but Is Essential for RANK- and Cytokine-Mediated Osteoclastogenesis

Xing, L., Bushnell, T. P., Carlson, L., Tai, Z., Tondravi, M., Siebenlist, U., Young, F., & Boyce, B. F. (2002) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2002.17.7.1200 · Cited by 165 · see citing works

Involvement of multiple myeloma cell-derived exosomes in osteoclast differentiation

Raimondi, L., Luca, A. D., Amodio, N., Manno, M., Raccosta, S., Taverna, S., Bellavia, D., Naselli, F., Fontana, S., Schillaci, O., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.3830 · Cited by 162 · see citing works

Control of RANKL gene expression

O’Brien, C. A. (2009) · Bone · doi:10.1016/j.bone.2009.08.050 · Cited by 164 · see citing works

RANK–RANKL signalling in cancer

Renema, N., Navet, B., Heymann, M., Lézot, F., & Heymann, D. (2016) · Bioscience Reports · doi:10.1042/bsr20160150 · Cited by 164 · see citing works

Factors regulating osteoclast formation in human tissues adjacent to peri-implant bone loss: expression of receptor activator NFκB, RANK ligand and osteoprotegerin

Crotti, T. N., Smith, M., Findlay, D. M., Zreiqat, H., Ahern, M. J., Weedon, H., Hatzinikolous, G., Capone, M., Holding, C. A., & Haynes, D. R. (2003) · Biomaterials · doi:10.1016/s0142-9612(03)00556-8 · Cited by 157 · see citing works

Root resorption and the OPG/RANKL/RANK system: a mini review

Tyrovola, J. B., Spyropoulos, M. N., Makou, M., & Perrea, D. N. (2008) · Journal of Oral Science · doi:10.2334/josnusd.50.367 · Cited by 142 · see citing works

Adenoviral VEGF‐A gene transfer induces angiogenesis and promotes bone formation in healing osseous tissues

Tarkka, T., Sipola, A., Jämsä, T. J., Soini, Y., Ylä‐Herttuala, S., Tuukkanen, J., & Hautala, T. (2003) · The Journal of Gene Medicine · doi:10.1002/jgm.392 · Cited by 145 · see citing works

An Increased Osteoprotegerin Serum Release Characterizes the Early Onset of Diabetes Mellitus and May Contribute to Endothelial Cell Dysfunction

Secchiero, P., Corallini, F., Pandolfi, A., Consoli, A., Candido, R., Fabris, B., Celeghini, C., Capitani, S., & Zauli, G. (2006) · American Journal Of Pathology · doi:10.2353/ajpath.2006.060398 · Cited by 144 · see citing works

Recent advances in multifactorial regulation of vascular calcification

Tintut, Y., & Demer, L. L. (2001) · Current Opinion in Lipidology · doi:10.1097/00041433-200110000-00012 · Cited by 142 · see citing works

(Sub)clinical cardiovascular disease is associated with increased bone loss and fracture risk; a systematic review of the association between cardiovascular disease and osteoporosis

den Uyl, D., Nurmohamed, M. T., van Tuyl, L. H. D., Raterman, H. G., & Lems, W. F. (2011) · Arthritis Research & Therapy · doi:10.1186/ar3224 · Cited by 139 · see citing works

Use of a proximity extension assay proteomics chip to discover new biomarkers for human atherosclerosis

Lind, L., Ärnlöv, J., Lindahl, B., Siegbahn, A., Sundström, J., & Ingelsson, E. (2015) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2015.07.023 · Cited by 138 · see citing works

RANKL Stimulates Inducible Nitric-oxide Synthase Expression and Nitric Oxide Production in Developing Osteoclasts

Zheng, H. X., Yu, X., Collin‐Osdoby, P., & Osdoby, P. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m513225200 · Cited by 137 · see citing works

Osteoprotegerin increases leukocyte adhesion to endothelial cells both in vitro and in vivo

Zauli, G., Corallini, F., Bossi, F., Fabio Fischetti, I., Durigutto, P., Celeghini, C., Tedesco, F., & Secchiero, P. (2007) · Blood · doi:10.1182/blood-2007-01-068395 · Cited by 133 · see citing works

EGFL6 Promotes Endothelial Cell Migration and Angiogenesis through the Activation of Extracellular Signal-regulated Kinase

Chim, S. M., Qin, A., Tickner, J. C., Pavlos, N. J., Davey, T., Wang, H., Guo, Y., Zheng, M., & Xu, J. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.187633 · Cited by 132 · see citing works

Pathophysiological roles of osteoprotegerin (OPG)

Reid, P. E., & Holen, I. (2008) · European Journal of Cell Biology · doi:10.1016/j.ejcb.2008.06.004 · Cited by 128 · see citing works

VEGF and bone cell signalling: an essential vessel for communication?

Clarkin, C., & Gerstenfeld, L. C. (2012) · Cell Biochemistry and Function · doi:10.1002/cbf.2911 · Cited by 130 · see citing works

The role of the TRAIL/TRAIL receptors system in hematopoiesis and endothelial cell biology

Zauli, G., & Secchiero, P. (2006) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2006.04.002 · Cited by 127 · see citing works

Murine and Chicken Chondrocytes Regulate Osteoclastogenesis by Producing RANKL in Response to BMP2

Usui, M., Xing, L., Drissi, H., Zuscik, M. J., O’Keefe, R. J., Chen, D., & Boyce, B. F. (2007) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.071025 · Cited by 128 · see citing works

Influence of the TGF-β Superfamily on Osteoclasts/Osteoblasts Balance in Physiological and Pathological Bone Conditions

Jann, J., Gascon, S., Roux, S., & Faucheux, N. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21207597 · Cited by 129 · see citing works

In situ expression of RANKL, RANK, osteoprotegerin and cytokines in osteoclasts of rat periodontal tissue

Ogasawara, T., Yoshimine, Y., Kiyoshima, T., Kobayashi, I., Matsuo, K., Akamine, A. A., & Sakai, H. (2003) · Journal of Periodontal Research · doi:10.1111/j.1600-0765.2004.00699.x · Cited by 125 · see citing works

TNF-related Activation-induced Cytokine (TRANCE) Induces Angiogenesis through the Activation of Src and Phospholipase C (PLC) in Human Endothelial Cells

Kim, Y.-M., Kim, Y.-M., Lee, Y. M., Kim, H.-S., Kim, J. D., Choi, Y., Kim, K.-W., Lee, S.-Y., & Kwon, Y. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m109434200 · Cited by 125 · see citing works

Novel Aspects on RANK Ligand and Osteoprotegerin in Osteoporosis and Vascular Disease

Sattler, A., Schoppet, M., Schaefer, J. R., & Hofbauer, L. C. (2003) · Calcified Tissue International · doi:10.1007/s00223-003-0011-y · Cited by 123 · see citing works

Estrogens in rheumatoid arthritis; the immune system and bone

Islander, U., Jochéms, C., Lagerquist, M. K., Forsblad‐d’Elia, H., & Carlsten, H. (2010) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2010.05.018 · Cited by 123 · see citing works

Vascular Endothelial Growth Factor Up-regulates Expression of Receptor Activator of NF-κB (RANK) in Endothelial Cells

Min, J., Kim, Y., Kim, Y., Kim, E.-C., Gho, Y. S., Kang, I., Lee, S.-Y., Kong, Y., & Kwon, Y. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m300539200 · Cited by 118 · see citing works

Human Microvascular Endothelial Cell Activation by IL-1 and TNF-α Stimulates the Adhesion and Transendothelial Migration of Circulating Human CD14+ Monocytes That Develop With RANKL Into Functional Osteoclasts

Kindle, L., Rothe, L., Kriss, M. S., Osdoby, P., & Collin‐Osdoby, P. (2006) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.051027 · Cited by 117 · see citing works

Imbalance of RANKL/RANK/OPG system in interface tissue in loosening of total hip replacement

Mandelin, J. M., Li, T.-F., Liljeström, M., Kroon, M. E., Hanemaaijer, R., Santavirta, S. S., & Konttinen, Y. T. (2003) · Journal of Bone and Joint Surgery - British Volume · doi:10.1302/0301-620x.85b8.13311 · Cited by 117 · see citing works

Local Production of Osteoprotegerin by Osteoblasts Suppresses Bone Resorption

Cawley, K. M., Bustamante-Gomez, N. C., Guha, A. G., MacLeod, R. S., Xiong, J., Gubrij, I., Liu, Y., Mulkey, R., Palmieri, M., Thostenson, J. D., et al. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.108052 · Cited by 114 · see citing works

Basic Fibroblast Growth Factor Stimulates Osteoclast Recruitment, Development, and Bone Pit Resorption in Association With Angiogenesis In Vivo on the Chick Chorioallantoic Membrane and Activates Isolated Avian Osteoclast Resorption In Vitro

Collin‐Osdoby, P., Rothe, L., Bekker, S., Anderson, F. L., Huang, Y., & Osdoby, P. (2002) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2002.17.10.1859 · Cited by 113 · see citing works

New Perspective in Osteoarthritis: The OPG and RANKL System as a Potential Therapeutic Target?

Tat, S. K., Pelletier, J.-P., Velasco, C. R., Padrines, M., & Martel-Pelletier, J. (2009) · The Keio Journal of Medicine · doi:10.2302/kjm.58.29 · Cited by 112 · see citing works

The role of interleukin-1 in bone resorption in rheumatoid arthritis

Strand, V. (2004) · British journal of rheumatology · doi:10.1093/rheumatology/keh202 · Cited by 110 · see citing works

Osteoprotegerin (OPG)—a potential new role in the regulation of endothelialcell phenotype and tumour angiogenesis?

Cross, S. S., Yang, Z., Brown, N. J., Balasubramanian, S. P., Evans, C. A., Woodward, J. K. L., Neville-Webbe, H. L., Down, J. M., Reed, M., Coleman, R. E., et al. (2005) · International Journal of Cancer · doi:10.1002/ijc.21606 · Cited by 108 · see citing works

Receptor activator of nuclear factor (NF)–κB ligand (RANKL) increases vascular permeability: impaired permeability and angiogenesis in eNOS-deficient mice

Min, J., Cho, Y.-L., Choi, J., Kim, Y., Kim, J. H., Yu, Y. S., Rho, J., Mochizuki, N., Kim, Y., Oh, G. T., et al. (2006) · Blood · doi:10.1182/blood-2006-06-029298 · Cited by 107 · see citing works

Rationale for the role of osteoclast‐like cells in arterial calcification

Doherty, T. M., Uzui, H., Fitzpatrick, L. A., Tripathi, P. V., Dunstan, C. R., Asotra, K., & Rajavashisth, T. B. (2002) · The FASEB Journal · doi:10.1096/fj.01-0898hyp · Cited by 104 · see citing works

RANKL Enhances Macrophage Paracrine Pro-Calcific Activity in High Phosphate-Treated Smooth Muscle Cells: Dependence on IL-6 and TNF-α

Deuell, K. A., Callegari, A., Giachelli, C. M., Rosenfeld, M. E., & Scatena, M. (2012) · Journal of Vascular Research · doi:10.1159/000341216 · Cited by 104 · see citing works

Metabolic Acidosis Stimulates RANKL RNA Expression in Bone Through a Cyclo-oxygenase-Dependent Mechanism

Frick, K. K., & Bushinsky, D. A. (2003) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2003.18.7.1317 · Cited by 104 · see citing works

Aortic valve calcification: basic science to clinical practice

Akat, K. M., Borggrefe, M. M., & Kaden, J. J. (2008) · Heart · doi:10.1136/hrt.2007.134783 · Cited by 103 · see citing works

The role of osteoprotegerin in cardiovascular disease

Montagnana, M., Lippi, G., Danese, E., & Guidi, G. C. (2012) · Annals of Medicine · doi:10.3109/07853890.2012.727019 · Cited by 98 · see citing works

RANKL regulates endothelial cell survival through the phosphatidylinositol 3′‐kinase/Akt signal transduction pathway

Kim, H., Shin, H. S., Kwak, H. J., Ahn, K. Y., Kim, J., Lee, H. J., Lee, M., Lee, Z. H., & Koh, G. Y. (2003) · The FASEB Journal · doi:10.1096/fj.03-0215fje · Cited by 99 · see citing works

HIV-1 Vpr enhances production of receptor of activated NF-κB ligand (RANKL) via potentiation of glucocorticoid receptor activity

Fakruddin, J. M., & Laurence, J. (2004) · Archives of Virology · doi:10.1007/s00705-004-0395-7 · Cited by 117 · see citing works

Osteoclast diseases

Helfrich, M. (2003) · Microscopy Research and Technique · doi:10.1002/jemt.10375 · Cited by 94 · see citing works

Role of the RANK/RANKL/OPG and Wnt/β-Catenin Systems in CKD Bone and Cardiovascular Disorders

Workgroup, O. B. O. T. E. R. O. (., Carrillo-López, N., Martínez-Arias, L., Fernández-Villabrille, S., Ruiz-Torres, M. P., Dusso, A., Cannata-Andía, J. B., Naves-Díaz, M., & Panizo, S. (2021) · Calcified Tissue International · doi:10.1007/s00223-020-00803-2 · Cited by 91 · see citing works

Osteoprotegerin in relation to body weight, lipid parameters insulin sensitivity, adipocytokines, and C-reactive protein in obese and non-obese young individuals: results from both cross-sectional and interventional study

Gannagé‐Yared, M., Yaghi, C., Habre, B., Khalifé, S., Noun, R. J., Germanos-Haddad, M., & Trak-Smayra, V. E. (2008) · European Journal of Endocrinology · doi:10.1530/eje-07-0797 · Cited by 93 · see citing works

The capability of plasma osteoprotegerin as a predictor of cardiovascular disease: a systematic literature review

Nybo, M., & Rasmussen, L. M. (2008) · European Journal of Endocrinology · doi:10.1530/eje-08-0554 · Cited by 93 · see citing works

Role of RANKL inhibition in osteoporosis

McClung, M. R. (2007) · Arthritis Research & Therapy · doi:10.1186/ar2167 · Cited by 93 · see citing works

Serum levels of osteoprotegerin and RANKL in patients with ST elevation acute myocardial infarction

Crisafulli, A., Micari, A., Altavilla, D., Saporito, F., Sardella, A., Passaniti, M., Raffa, S., D'Anneo, G., Lucà, F., Mioni, C., et al. (2005) · Clinical Science · doi:10.1042/cs20050058 · Cited by 92 · see citing works

Osteoprotegerin Is Associated With Silent Coronary Artery Disease in High-Risk but Asymptomatic Type 2 Diabetic Patients

Avignon, A., Sultan, A., Piot, C. A., Elaerts, S., Cristol, J., & Dupuy, A. (2005) · Diabetes Care · doi:10.2337/diacare.28.9.2176 · Cited by 92 · see citing works

Skeleton-vasculature chain reaction: a novel insight into the mystery of homeostasis

Chen, M., Li, Y., Huang, X., Gu, Y., Li, S., Yin, P., Zhang, L., & Tang, P. (2021) · Bone Research · doi:10.1038/s41413-021-00138-0 · Cited by 95 · see citing works

Osteoprotegerin and RANKL differentially regulate angiogenesis and endothelial cell function

McGonigle, J. S., Giachelli, C. M., & Scatena, M. (2008) · Angiogenesis · doi:10.1007/s10456-008-9127-z · Cited by 90 · see citing works

Inhibition of interleukin‐1 but not tumor necrosis factor suppresses neovascularization in rat models of corneal angiogenesis and adjuvant arthritis

Coxon, A., Bolon, B. N., Estrada, J., Kaufman, S., Scully, S. A., Rattan, A., Duryea, D., Hu, Y., Rex, K. L., Pacheco, E., et al. (2002) · Arthritis & Rheumatism · doi:10.1002/art.10546 · Cited by 89 · see citing works

Inhibition of p38 Mitogen-Activated Protein Kinase Prevents Inflammatory Bone Destruction

Mbalaviele, G., Anderson, G. D., Jones, A., Ciechi, P. D., Settle, S., Mnich, S., Thiede, M. A., Abu‐Amer, Y., Portanova, J. P., & Monahan, J. B. (2006) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.105.100362 · Cited by 87 · see citing works

Transforming Growth Factor-β Induces Expression of Receptor Activator of NF-κB Ligand in Vascular Endothelial Cells Derived from Bone

Ishida, A., Fujita, N., Kitazawa, R., & Tsuruo, T. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m111093200 · Cited by 86 · see citing works

Morphometric evaluation of the frontal sinus in relation to age

Fătu, C., Puisoru, M., Rotaru, M., & Truta, A. M. (2006) · Annals of Anatomy - Anatomischer Anzeiger · doi:10.1016/j.aanat.2005.11.012 · Cited by 84 · see citing works

Distinct gene expression of receptor activator of nuclear factor-κB and rank ligand in the inflammatory response to variant morphologies of UHMWPE particles

Ren, W., Yang, S.-Y., Fang, H.-W., Hsu, S., & Wooley, P. H. (2003) · Biomaterials · doi:10.1016/s0142-9612(03)00384-3 · Cited by 84 · see citing works

Increased AP-1 and NF-κB activation and recruitment with the combination of the proinflammatory cytokines IL-1β, tumor necrosis factor alpha and IL-17 in rheumatoid synoviocytes

Granet, C., Maslinski, W., & Miossec, P. (2004) · Arthritis Research & Therapy · doi:10.1186/ar1159 · Cited by 84 · see citing works

Causes of Age-Related Bone Loss and Bone Fragility: An Alternative View

Raisz, L. G., & Seeman, E. (2001) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2001.16.11.1948 · Cited by 82 · see citing works

Interleukin-4 and Interleukin-13 Stimulate the Osteoclast Inhibitor Osteoprotegerin by Human Endothelial Cells Through the STAT6 Pathway

Stein, N., Kreutzmann, C., Zimmermann, S.-P., Niebergall, U., Hellmeyer, L., Goettsch, C., Schoppet, M., & Hofbauer, L. C. (2008) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.080203 · Cited by 81 · see citing works

Role of receptor activator of nuclear factor-κB ligand and osteoprotegerin in bone cell biology

Hofbauer, L. C., & Heufelder, A. E. (2001) · Journal of Molecular Medicine · doi:10.1007/s001090100226 · Cited by 586 · see citing works

Human Microvascular Endothelial Cell Activation by IL-1 and TNF-α Stimulates the Adhesion and Transendothelial Migration of Circulating Human CD14+ Monocytes That Develop With RANKL Into Functional Osteoclasts

Kindle, L., Rothe, L., Kriss, M. S., Osdoby, P., & Collin‐Osdoby, P. (2006) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.051027 · Cited by 117 · see citing works

The Effect of Paricalcitol on Osteoprotegerin Production by Human Peripheral Blood Mononuclear Cells

Eleftheriadis, T., Antoniadi, G., Liakopoulos, V., & Galaktidou, G. (2009) · The Journal of Rheumatology · doi:10.3899/jrheum.080987 · Cited by 6 · see citing works

VEGF-C, a Lymphatic Growth Factor, Is a RANKL Target Gene in Osteoclasts That Enhances Osteoclastic Bone Resorption through an Autocrine Mechanism

Zhang, Q., Guo, R., Lu, Y., Zhao, L., Zhou, Q., Schwarz, E. M., Huang, J. L., Chen, D., Jin, Z., Boyce, B. F., et al. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m708055200 · Cited by 86 · see citing works